Arena Pharma (ARNA), Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets

Go back to Arena Pharma (ARNA), Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets

Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets

January 2, 2020 8:30 AM EST

SAN DIEGO, Jan. 2, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Beacon Discovery today announced that they entered into a strategic multi-year partnership (Project Cabrillo) aimed at building novel medicines across a range of G protein-coupled receptor... More